.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Covington
Harvard Business School
Johnson and Johnson
US Army
Teva
Merck
McKesson
Cerilliant
Express Scripts

Generated: September 25, 2017

DrugPatentWatch Database Preview

Drug Master Files for: irinotecan

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
17312AII4/20/2004SCINOPHARM TAIWAN LTDIRINOTECAN HYDROCHLORIDE
17348III5/13/2004CHEMWERTH INCIRINOTECAN HCL (NON-STERILE BULK DRUG SUBSTANCE)
17456AII6/8/2004CIPLA LTDIRINOTECAN HYDROCHLORIDE TRIHYDRATE USP
18818AII9/23/2005FRESENIUS KABI ONCOLOGY LTDIRINOTECAN HYDROCHLORIDE TRIHYDRATE
18891AII10/20/2005YAKULT HONSHA CO LTDTOTAL SYNTHESIS OF TSN-38B-11 INTERMEDIATE COMPOUND USED IN THE MANUFACTURE OF IRINOTECAN HYDROCHLORIDE TRIHYRATE (CPT-11) DRUG SUBSTANCE
18969III10/30/2005POLYMED THERAPEUTICS INCIRINOTECAN HYDROCHLORIDE TRIHYDRATE (NON-STERILE BULK) DRUG SUBSTANCE
19050AII12/20/2005PLIVA-LACHEMA ASIRINOTECAN HYDROCHLORIDE TRIHYDRATE
19222III3/6/2006TERUMO CORPIHL- 305 IRINOTECAN LIPOSOME INJECTION
19661III7/27/2006SAI PHYTOCEUTICALS PVT LTDIRINOTECAN HYDROCHLORIDE TRIHYDRATE
20195III1/12/2007SUN PHARMACEUTICAL INDUSTRIES LTDIRINOTECAN HYDROCHLORIDE TRIHYDRATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Harvard Business School
Federal Trade Commission
Johnson and Johnson
Julphar
Teva
Cantor Fitzgerald
Novartis
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot